3-methoxytyramine has been researched along with haloperidol in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (43.75) | 18.7374 |
| 1990's | 8 (50.00) | 18.2507 |
| 2000's | 1 (6.25) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Egan, MF; Karoum, F | 1 |
| Brown, EE; Cumming, P; Damsma, G; Fibiger, HC | 1 |
| Egan, MF; Karoum, F; Wyatt, RJ | 1 |
| Chance, WT; Fischer, JE; Foley-Nelson, T; Nelson, JL | 1 |
| Salama, AI; Saller, CF | 1 |
| Altar, CA; Boyar, WC | 1 |
| Itoh, T; Kohori, I; Masuda, Y; Murai, S; Saito, H | 1 |
| Altar, CA; Kim, HS; Wood, PL | 1 |
| Blum, W; Lauber, J; Richter, WJ; Waldmeier, PC | 1 |
| Spaan, SJ; Westerink, BH | 1 |
| Achilli, G; Algeri, S; Perego, C; Ponzio, F | 1 |
| Chrapusta, SJ; Egan, MF; Lipska, BK; Weinberger, DR | 1 |
| Chrapusta, SJ; Egan, MF; Karoum, F | 1 |
| Chrapusta, SJ; Egan, MF; Karoum, F; Wyatt, RJ | 1 |
| Chrapusta, S; Egan, MF; Karoum, F; Lipska, BK; Wyatt, RJ | 1 |
| Adachi, YU; Aramaki, Y; Higuchi, H; Satomoto, M; Watanabe, K | 1 |
1 review(s) available for 3-methoxytyramine and haloperidol
| Article | Year |
|---|---|
Effects of chronic neuroleptic treatment on dopamine release: insights from studies using 3-methoxytyramine.
Topics: Animals; Antipsychotic Agents; Clozapine; Dopamine; Haloperidol; Humans; Neurons; Reproducibility of Results; Time Factors | 1996 |
15 other study(ies) available for 3-methoxytyramine and haloperidol
| Article | Year |
|---|---|
Dopamine release and metabolism in the rat frontal cortex, nucleus accumbens, and striatum: a comparison of acute clozapine and haloperidol.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Biogenic Monoamines; Brain Chemistry; Clozapine; Corpus Striatum; Dopamine; Frontal Lobe; Haloperidol; Homovanillic Acid; Male; Nucleus Accumbens; Pargyline; Rats; Rats, Inbred Strains | 1992 |
Interstitial 3-methoxytyramine reflects striatal dopamine release: an in vivo microdialysis study.
Topics: 3,4-Dihydroxyphenylacetic Acid; 4-Butyrolactone; Animals; Antidepressive Agents; Apomorphine; Bupropion; Corpus Striatum; Dialysis; Dopamine; Haloperidol; Homovanillic Acid; Kinetics; Male; Propiophenones; Rats; Rats, Inbred Strains; Tetrodotoxin | 1991 |
Effects of acute and chronic clozapine and haloperidol administration on 3-methoxytyramine accumulation in rat prefrontal cortex, nucleus accumbens and striatum.
Topics: Animals; Brain; Cerebral Cortex; Chromatography, Gas; Clozapine; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Haloperidol; Male; Nucleus Accumbens; Rats; Rats, Inbred Strains | 1991 |
Tyrosine loading increases dopamine metabolite concentrations in the brain.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Dopamine; Haloperidol; Homovanillic Acid; Male; Rats; Rats, Inbred Strains; Tyrosine | 1990 |
3-Methoxytyramine accumulation: effects of typical neuroleptics and various atypical compounds.
Topics: 4-Butyrolactone; Animals; Antipsychotic Agents; Apomorphine; Benzazepines; Buspirone; Carbazoles; Chlorpromazine; Clozapine; Corpus Striatum; Dopamine; Dopamine Antagonists; Fluphenazine; Haloperidol; Male; Molindone; Pargyline; Pyrimidines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Regression Analysis | 1986 |
Modulation of in vivo dopamine release by D2 but not D1 receptor agonists and antagonists.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; 3,4-Dihydroxyphenylacetic Acid; Animals; Benzazepines; Benzopyrans; Brain; Dopamine; Dopamine Antagonists; Dose-Response Relationship, Drug; Ergolines; Haloperidol; Homovanillic Acid; Kinetics; Male; Metoclopramide; Mice; Quinpirole; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2 | 1987 |
Repeated low dose apomorphine induced subsensitivity of presynaptic dopamine receptors.
Topics: Animals; Apomorphine; Behavior, Animal; Corpus Striatum; Dopamine; Drug Tolerance; Haloperidol; Male; Mice; Motor Activity; Receptors, Dopamine | 1987 |
In vivo assessment of dopamine and norepinephrine release in rat neocortex: gas chromatography-mass spectrometry measurement of 3-methoxytyramine and normetanephrine.
Topics: Animals; Cerebral Cortex; Clonidine; Dopamine; Gas Chromatography-Mass Spectrometry; Haloperidol; Male; Nomifensine; Norepinephrine; Normetanephrine; Pargyline; Rats; Rats, Inbred Strains | 1987 |
3-Methoxytyramine: its suitability as an indicator of synaptic dopamine release.
Topics: Animals; Baclofen; Catechol O-Methyltransferase; Chromatography, Gas; Clorgyline; Dopamine; Female; Haloperidol; Mass Spectrometry; Rats; Synapses; Synaptic Transmission | 1981 |
On the significance of endogenous 3-methoxytyramine for the effects of centrally acting drugs on dopamine release in the rat brain.
Topics: 3,4-Dihydroxyphenylacetic Acid; 4-Butyrolactone; Animals; Apomorphine; Benztropine; Brain; Chlorpromazine; Dextroamphetamine; Dopamine; Female; Haloperidol; Homovanillic Acid; Kinetics; Morphine; Nomifensine; Oxotremorine; Rats; Rats, Inbred Strains; Reserpine | 1982 |
Differential effects of certain dopaminergic drugs on the striatal concentration of dopamine metabolites, with special reference to 3-methoxytramine.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Clozapine; Corpus Striatum; Dopamine; Haloperidol; Homovanillic Acid; Male; Nomifensine; Phenylacetates; Piribedil; Quipazine; Rats | 1981 |
Neonatal excitotoxic ventral hippocampal damage alters dopamine response to mild repeated stress and to chronic haloperidol.
Topics: Animals; Corpus Striatum; Dopamine; Female; Frontal Lobe; Haloperidol; Handling, Psychological; Hippocampus; Ibotenic Acid; Nerve Degeneration; Neurotoxins; Pargyline; Rats; Rats, Sprague-Dawley; Sodium Chloride; Stress, Psychological | 1995 |
3-Methoxytyramine is the major metabolite of released dopamine in the rat frontal cortex: reassessment of the effects of antipsychotics on the dynamics of dopamine release and metabolism in the frontal cortex, nucleus accumbens, and striatum by a simple t
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antipsychotic Agents; Clozapine; Corpus Striatum; Dopamine; Frontal Lobe; Haloperidol; Kinetics; Male; Methylation; Models, Biological; Nucleus Accumbens; Rats; Rats, Sprague-Dawley | 1994 |
Haloperidol and clozapine increase intraneuronal dopamine metabolism, but not gamma-butyrolactone-resistant dopamine release.
Topics: 3,4-Dihydroxyphenylacetic Acid; 4-Butyrolactone; Animals; Brain Chemistry; Cerebral Cortex; Clozapine; Dopamine; Dopamine Antagonists; Haloperidol; Homovanillic Acid; Male; Neurons; Rats; Rats, Sprague-Dawley; Receptors, Dopamine | 1993 |
Halothane attenuated haloperidol and enhanced clozapine-induced dopamine release in the rat striatum.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antipsychotic Agents; Clozapine; Corpus Striatum; Dopamine; Haloperidol; Halothane; Homovanillic Acid; Kinetics; Male; Rats; Rats, Sprague-Dawley | 2003 |